SB 433 Georgia Senate · 2019-2020 Regular Session

'Diabetes Drug Pricing Transparency Act of 2020'; disclosure of diabetes prescription drug pricing; require

Summary
A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to require disclosure of diabetes prescription drug pricing; to provide for a short title; to provide for legislative findings; to provide for definitions; to provide for a listing of diabetes prescription drugs; to provide for drug manufacturer and pharmacy benefits manager report forms and insurer pricing reports; to provide for certain other reports; to provide for penalties; to amend Chapter 1 of Title 10 of the Official Code of Georgia Annotated, relating to selling and other trade practices, so as to provide for penalties regarding unfair or deceptive practices in consumer transactions; to provide for related matters; to provide for an effective date and applicability; to repeal conflicting laws; and for other purposes.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2020
Committee Review
Floor Vote
Governor
Introduced Feb 24, 2020 Last action Feb 25, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Feb 25, 2020
Committee
Senate Read and Referred
upper
5 primary · 0 co-sponsors

Sponsors